查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
聚乙二醇化蛋白质市场规模,份额和趋势分析报告按蛋白质类型（脑脊液,干扰素）,应用（癌症,肝炎）,产品/服务（消耗品,服务）,用户和细分市场预测2022-2030
市场调查报告书
商品编码
1147620

聚乙二醇化蛋白质市场规模,份额和趋势分析报告按蛋白质类型（脑脊液,干扰素）,应用（癌症,肝炎）,产品/服务（消耗品,服务）,用户和细分市场预测2022-2030

PEGylated Proteins Market Size, Share & Trends Analysis Report By Protein Type (CSF, Interferons), By Application (Cancer, Hepatitis), By Product & Services (Consumables, Services), By End-user, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

聚乙二醇化蛋白质市场增长和趋势

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球聚乙二醇化蛋白质市场规模预计将达到 30.6 亿美元，预测期内的复合年增长率为 11.71%。聚乙二醇化是将聚乙二醇聚合物链共价和非共价连接到治疗剂、药物和囊泡等分子上的过程。聚乙二醇化化合物还提供有助于行业扩张的其他优势，例如改进的抗蛋白水解、延长的半衰期、低毒性和低免疫原性。

另一方面，聚乙二醇化工艺成本上升和部分药物专利到期预计将在一定程度上製约行业扩张。然而，与非蛋白质药物相比，蛋白质药物越来越受欢迎，聚乙二醇化提高了蛋白质稳定性和循环半衰期，推动了预测期内聚乙二醇化蛋白质行业的增长。预计癌症、肾病和类风湿性关节炎等慢性病发病率上升是工业扩张的主要驱动力。例如，IARC（国际癌症研究机构）估计2020 年全球将有 1030 万癌症死亡和 1930 万癌症新病例。

此外，在每年 2950 万新病例中，预计到 2040 年将有 1640 万人死于癌症相关原因。根据联合国爱滋病毒/爱滋病联合规划署 (UNAIDS) 情况说明书“2021 年全球爱滋病毒和爱滋病统计数据”，到 2020 年，全球将有 3770 万人被诊断为爱滋病毒阳性。因此，随着全球慢性病和传染病的负担，对製造药品的需求预计将增长。这将促进研究并促进行业发展。预计 COVID-19 将对该行业产生积极影响。

根据 2021 年 6 月发表的题为“聚乙二醇化纳米颗粒白蛋白结合的甾体人参皂甘衍生物减轻 SARS-CoV-2 介导的过度炎症反应”的研究，SARS-CoV-2 ICU 患者发现聚乙二醇化纳米颗粒白蛋白结合(PNAB)-steroidal ginsenoside 可以成功降低组蛋白 H4 和 NETosis 相关因子的血浆水平，并减少 SREBP2 介导的全身炎症。 PNAB 甾体人参皂甘药物可能有助于治疗严重 SARS-CoV-2 患者常见的凝血和细胞因子风暴症状。因此，鑑于使用聚乙二醇化技术开展了大量研究活动，COVID-19 大流行对该行业产生了积极影响。

此外，製药和生物技术公司加大对研发项目的投资也在推动该行业的扩张。例如，2022 年 3 月，Flow Eighteen38 的母公司 CRO FairJourneyBiologics S.A. 是一家蛋白质科学部门，旨在加强和加快抗体表征和蛋白质纯化项目，将扩大该部门的蛋白质生产以及物理和生物学表征。它已宣布对评估能力和服务的 500 万欧元（558 万美元）投资。预计此类投资将补充整体市场增长。过去几年也出现了明显的行业整合趋势，主要参与者建立战略合作伙伴关係以支持研发项目。

例如，2022 年 2 月，Merck KGaA 收购了 Exelead，这是一家专注于聚乙二醇化药物和结合基于脂质纳米颗粒 (LNP) 的药物输送技术的复杂注射剂的生物製药 CDMO。此外，2022 年 7 月，欧洲药品管理局 (EMA) 人用药品委员会 (CHMP) 批准了盐酸多柔比星（Celdoxome 聚乙二醇化脂质体）用于晚期卵巢癌、转移性乳腺癌、艾滋病相关卡波西肉瘤，推荐批准用于治疗晚期多发性骨髓瘤。从而促进行业的发展。

聚乙二醇化蛋白质市场报告要点

由于越来越多地使用基于试剂盒的聚乙二醇化产品线，耗材产品和服务部分将在 2021 年占据最大份额

2021年，集落刺激因子蛋白类细分市场占比较大。集落刺激因子促进血细胞的发育并改善其功能，从而有助于在癌症治疗期间增强人体的免疫力。

因此，集落刺激因子在肿瘤学中的广泛使用将推动这一领域的增长。

由于全球癌症的高发以及多□治疗癌症的利用，2021年癌症应用领域将占据很大份额。

2021 年，製药和生物技术最终用户部分所占份额最大

生物技术和製药公司在聚乙二醇化蛋白质方面不断增加的研发支出将进一步推动细分市场的增长

由于单克隆抗体、促红细胞生成素和干扰素等治疗慢性疾病的生物製剂的大量使用、政府资金的增加、对研究活动的资助以及正在进行的聚乙二醇化蛋白质项目，2021 年北美成为

由于靶向疾病的增加和聚乙二醇化蛋白质的高采用率，预计亚太地区在预测期内将以最高的复合年增长率增长。

内容

第 1 章调查方法及范围

  • 调查方法
  • 调查假设
  • 调查方法
  • 资讯采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要资讯
    • 初步调查
  • 资讯或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细资讯
    • 商品流分析
      • 方法 1：商品流方法
      • 方法 2：使用自下而上的方法按国家/地区进行市场预测
  • 全球市场：CAGR 计算
  • 二级资讯列表
  • 主要资讯列表
  • 目的

第 2 章执行摘要

  • 2021 年市场概况

第 3 章市场变量、趋势和范围

  • 市场细分和范围
  • 市场动态
    • 市场促进因素分析
      • 蛋白质类药物的采用率增加
      • 治疗性蛋白质聚乙二醇化的好处
      • 生物製剂研发费用增加
    • 市场抑制因素分析
      • 聚乙二醇化生产过程的成本很高
      • 新型聚乙二醇化生物製品的专利到期
  • 2021 年渗透率和增长前景图
  • COVID-19 影响分析
  • 聚乙二醇化蛋白质市场分析工具
    • SWOT 分析，按因素（政治和法律、经济、技术）
    • 波特的五力分析

第 4 章产品和服务的业务分析

  • 聚乙二醇化蛋白质市场：产品和服务的变化分析
  • 消耗品
  • 服务

第5章蛋白质类业务分析

  • 聚乙二醇化蛋白质市场：蛋白质类型的变异分析
  • 集落刺激因子
  • 干扰素
  • 促红细胞生成素
  • 重组因子 VII
  • 其他

第 6 章应用业务分析

  • 聚乙二醇化蛋白质市场：应用变化分析
  • 癌症
  • 自身免疫性疾病
  • 肝炎
  • 多发性硬化症
  • 血友病
  • 胃肠道疾病
  • 其他

第 7 章最终用户业务分析

  • 聚乙二醇化蛋白质市场：最终用户差异分析
  • 製药和生物技术公司
  • 委託研究机构
  • 学术和研究机构

第 8 章区域业务分析

  • 聚乙二醇化蛋白质市场：区域差异分析
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 意大利
    • 西班牙
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国

第 9 章竞争格局

  • 战略框架
  • 公司简介
    • Thermo Fisher Scientific, Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • ABCAM PLC
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • ENZON PHARMACEUTICALS, INC.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • MERCK KGAA
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • CELARES GMBH
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • PROFACGEN
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • CREATIVE PEGWORKS
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • NOF CORPORATION
      • 公司简介
      • NOF 美国公司
      • 财务业绩
      • 产品基准
      • 战略举措
    • AURIGENE PHARMACEUTICAL SERVICES LTD.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • LAYSAN BIO, INC.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
Product Code: GVR-4-68039-990-1

PEGylated Proteins Market Growth & Trends:

The global PEGylated proteins market size is expected to reach USD 3.06 billion by 2030, registering a CAGR of 11.71% over the forecast period, according to a new report by Grand View Research, Inc. PEGylation is the process of attaching polyethylene glycol polymer chains to molecules, such as therapeutics, medication, or vesicle, covalently & non-covalently. The industry is anticipated to grow significantly over the projected period, primarily as a result of the rising demand for PEGylation, an increase in the prevalence of chronic diseases, and the existence of potent new treatment candidates.PEGylated compounds also have certain additional benefits that contribute to the industry expansion, including increased proteolytic protection, a longer half-life, lower toxicity, and lower immunogenicity.

On the other hand, increased PEGylation process costs and the patent expiration of some medications are anticipated to restrain industry expansion to some extent. However, the growing preference for protein-based medications over non-protein-based drugs and the improvement of protein stability and circulation half-life by PEGylation is expected to propel the PEGylated protein industry growth in the forecast period. The rising incidence of chronic diseases like cancer, kidney disease, and rheumatoid arthritis is the main factor contributing to the industry's expansion. For instance, the IARC (International Agency for Research on Cancer) estimates that there were 10.3 million cancer deaths and 19.3 million new cases of cancer worldwide in 2020.

Furthermore, 16.4 million people are expected to die from cancer-related causes by 2040, out of an estimated 29.5 million new instances of the disease per year. In addition, 37.7 million people worldwide were diagnosed HIV positive in 2020, according to the Global HIV and AIDS Statistics 2021 fact sheet from the Joint United Nations Program on HIV/AIDS (UNAIDS). As a result, the demand for producing medicines is anticipated to rise along with the burden of chronic & infectious diseases across the globe. This will encourage research and propel the industry's growth. It is anticipated that COVID-19 had a positive effect on the industry.

According to a study titled "PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives alleviate SARS-CoV-2-mediated hyper-inflammatory responses," published in June 2021, in SARS-CoV-2 ICU patients, PEGylated Nanoparticle Albumin-Bound (PNAB)-steroidal Ginsenoside can successfully reduce plasma levels of histone H4 and NETosis-related factors and reduce SREBP2-mediated systemic inflammation. PNAB-steroidal ginsenoside drugs may help treat coagulation and cytokine storm symptoms that are common in severe SARS-CoV-2 patients. Therefore, the COVID-19 pandemic had a favorable impact on the industry given the considerable research activities conducted using PEGylation technology.

In addition, the industry expansion is being boosted by the rising investments made in R&D projects by pharmaceutical and biotechnology firms. For instance, in March 2022, CRO FairJourneyBiologics S.A., the parent company of Flow Eighteen38, a division of protein sciences, established to enhance and expedite antibody characterization as well as protein purification projects, announced an investment of EUR 5 million (USD 5.58 million) into the division's protein production and physical and biological characterization capabilities and services. Such investments are anticipated to supplement the overall market growth. In addition, there is a discernible trend toward industry consolidation over the past years, with key players forming strategic partnerships to support the R&D projects.

For instance, in February 2022, Merck KGaA acquired Exelead, a biopharmaceutical CDMO with a focus on PEGylated pharmaceuticals and intricate injectable formulations, incorporating Lipid Nanoparticle (LNP)-based drug delivery technology. Furthermore, in July 2022, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP), Doxorubicin hydrochloride (Celdoxome pegylated liposomal) was recommended for approval for the cure of advanced ovarian cancer, metastatic breast cancer, AIDS-related Kaposi's sarcoma, and progressing multiple myeloma. Thus, propelling the industry's growth.

PEGylated Proteins Market Report Highlights:

  • The consumables product & service segment accounted for the largest share in 2021 due to the growing usage of kit-based PEGylation product lines
  • The colony-stimulating factor protein type segment held a larger share in 2021. Colony-stimulating chemicals speed up the development of blood cells and improve their functionality, therefore they help boost a person's immune system while they are receiving cancer treatment
  • Thus, extensive use of colony-stimulating factors in oncology will promote the growth of this segment
  • The cancer application segment held a larger share in 2021 due to the high incidence of cancer worldwide and the use of peptide therapy for cancer
  • The pharmaceutical & biotechnology companies end-user segment held the largest share in 2021
  • The rising R&D expenditure by biotechnology and pharmaceutical firms for PEGylated protein will further boost the segment growth
  • North America was the largest region in 2021 due to the high use of biological medications for the treatment of chronic diseases, such as monoclonal antibodies, erythropoietin, and interferon, as well as rising government funding, funding for research activities, and ongoing projects for PEGylated protein
  • Asia Pacific is expected to grow at the highest CAGRover the forecast period due to the rising prevalence of target diseases and high PEGylated protein adoption

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 Gvr's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
  • 1.5 Information Or Data Analysis
    • 1.5.1 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
      • 1.7.1.1 Approach 1: Commodity Flow Approach
      • 1.7.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
  • 1.8 Global Market: CAGR Calculation
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Market Snapshot, 2021

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market Dynamics
    • 3.2.1 Market Drivers Analysis
      • 3.2.1.1 Increasing Adoption Of Proteins Based Drugs
      • 3.2.1.2 Advantages Of Pegylation Of Therapeutic Proteins
      • 3.2.1.3 Increased Spending On R&D Of Biologics
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High cost of production process for PEGylation
      • 3.2.2.2 Patent expiration for novel PEGylated biologics
  • 3.3 Penetration and Growth Prospect Mapping, 2021
  • 3.4 COVID - 19 Impact Analysis
  • 3.5 PEGylated Proteins Market Analysis Tools
    • 3.5.1 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
    • 3.5.2 Porter's Five Forces Analysis

Chapter 4 Product & Services Business Analysis

  • 4.1 Pegylated Proteins Market: Product & Services Movement Analysis
  • 4.2 Consumables
    • 4.2.1 Global Pegylated Proteins Market For Consumables Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.3 Services
    • 4.3.1 Global Pegylated Proteins Market For Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 Protein Type Business Analysis

  • 5.1 PEGylated Proteins Market: Protein Type Movement Analysis
  • 5.2 Colony - stimulating factor
    • 5.2.1 Global Pegylated Proteins Market For Colony - Stimulating Factor Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 Interferons
    • 5.3.1 Global Pegylated Proteins Market For Interferons Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Erythropoietin
    • 5.4.1 Global Pegylated Proteins Market For Erythropoietin Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5 Recombinant Factor Vii
    • 5.5.1 Global Pegylated Proteins Market For Recombinant Factor Vii Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6 Others
    • 5.6.1 Global Pegylated Proteins Market For Other Proteins Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Application Business Analysis

  • 6.1 Pegylated Proteins Market: Application Movement Analysis
  • 6.2 Cancer
    • 6.2.1 Global Pegylated Proteins Market For Cancer Estimates And Forecast, 2018 - 2030
  • 6.3 Autoimmune Diseases
    • 6.3.1 Global Pegylated Proteins Market For Autoimmune Diseases Estimates And Forecast, 2018 - 2030
  • 6.4 Hepatitis
    • 6.4.1 Global Pegylated Proteins Market For Hepatitis Estimates And Forecast, 2018 - 2030
  • 6.5 Multiple Sclerosis
    • 6.5.1 Global Pegylated Proteins Market For Multiple Sclerosis Estimates And Forecast, 2018 - 2030
  • 6.6 Hemophilia
    • 6.6.1 Global Pegylated Proteins Market For Hemophilia Estimates And Forecast, 2018 - 2030
  • 6.7 Gastrointestinal Disorders
    • 6.7.1 Global Pegylated Proteins Market For Gastrointestinal Disorders Estimates And Forecast, 2018 - 2030
  • 6.8 Others
    • 6.8.1 Global Pegylated Proteins Market For Other Applications Estimates And Forecast, 2018 - 2030

Chapter 7 End - user Business Analysis

  • 7.1 PEGylated Proteins Market: End - user Movement Analysis
  • 7.2 Pharmaceutical & Biotechnology Companies
    • 7.2.1 Global Pegylated Proteins Market For Pharmaceutical & Biotechnology Companies Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.3 Contract Research Organizations
    • 7.3.1 Global Pegylated Proteins Market For Contract Research Organizations Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4 Academic & Research Institutes
    • 7.4.1 Global Pegylated Proteins Market For Academic & Research Institutes Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Regional Business Analysis

  • 8.1 PEGylated Proteins Market: Regional Movement Analysis
  • 8.2 North America
    • 8.2.1 North America Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.2 Germany
      • 8.3.2.1 Germany Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.3 France
      • 8.3.3.1 France Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.4 U.K.
      • 8.3.4.1 U.K. Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.5 Italy
      • 8.3.5.1 Italy Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.6 Spain
      • 8.3.6.1 Spain Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4 Asia - Pacific
    • 8.4.1 Asia - Pacific Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 India Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.5 Australia
      • 8.4.5.1 Australia Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.6 South Korea
      • 8.4.6.1 South Korea Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.4 Argentina
      • 8.5.4.1 Argentina Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6 Middle East And Africa
    • 8.6.1 Middle - East And Africa Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Saudi Arabia PEGylated Proteins market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.4 UAE
      • 8.6.4.1 UAE PEGylated Proteins market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 COMPETITIVE LANDSCAPE

  • 9.1 Strategy Framework
  • 9.2 Company Profiles
    • 9.2.1 THERMO FISHER SCIENTIFIC, INC.
      • 9.2.1.1 Company overview
      • 9.2.1.2 Financial performance
      • 9.2.1.3 Product benchmarking
      • 9.2.1.4 Strategic initiatives
    • 9.2.2 ABCAM PLC
      • 9.2.2.1 Company overview
      • 9.2.2.2 Financial performance
      • 9.2.2.3 Product benchmarking
      • 9.2.2.4 Strategic initiatives
    • 9.2.3 ENZON PHARMACEUTICALS, INC.
      • 9.2.3.1 Company overview
      • 9.2.3.2 Financial performance
      • 9.2.3.3 Product benchmarking
      • 9.2.3.4 Strategic initiatives
    • 9.2.4 MERCK KGAA
      • 9.2.4.1 Company overview
      • 9.2.4.2 Financial performance
      • 9.2.4.3 Product benchmarking
      • 9.2.4.4 Strategic initiatives
    • 9.2.5 CELARES GMBH
      • 9.2.5.1 Company overview
      • 9.2.5.2 Financial performance
      • 9.2.5.3 Product benchmarking
      • 9.2.5.4 Strategic initiatives
    • 9.2.6 PROFACGEN
      • 9.2.6.1 Company overview
      • 9.2.6.2 Financial performance
      • 9.2.6.3 Product benchmarking
      • 9.2.6.4 Strategic initiatives
    • 9.2.7 CREATIVE PEGWORKS
      • 9.2.7.1 Company overview
      • 9.2.7.2 Financial performance
      • 9.2.7.3 Product benchmarking
      • 9.2.7.4 Strategic initiatives
    • 9.2.8 NOF CORPORATION
      • 9.2.8.1 Company overview
      • 9.2.8.1.1 NOF AMERICA CORPORATION
      • 9.2.8.2 Financial performance
      • 9.2.8.3 Product benchmarking
      • 9.2.8.4 Strategic initiatives
    • 9.2.9 AURIGENE PHARMACEUTICAL SERVICES LTD.
      • 9.2.9.1 Company overview
      • 9.2.9.2 Financial performance
      • 9.2.9.3 Product benchmarking
      • 9.2.9.4 Strategic initiatives
    • 9.2.10 LAYSAN BIO, INC.
      • 9.2.10.1 Company overview
      • 9.2.10.2 Financial performance
      • 9.2.10.3 Product benchmarking
      • 9.2.10.4 Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 4 Global PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 5 Global PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 7 Global PEGylated Proteins Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America PEGylated Proteins Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 10 North America PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 11 North America PEGylated Proteins Market, Application, 2018 - 2030 (USD Million)
  • Table 12 North America PEGylated Proteins Market, End - user, 2018 - 2030 (USD Million)
  • Table 13 U.S. PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 14 U.S. PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 15 U.S. PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 16 U.S. PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 17 Canada PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 18 Canada PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 19 Canada PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 20 Canada PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 21 Europe PEGylated Proteins Market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 23 Europe PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 24 Europe PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 25 Europe PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 26 Germany PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 27 Germany PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 28 Germany PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 29 Germany PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 30 U.K. PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 31 U.K. PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 32 U.K. PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 U.K. PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 34 France PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 35 France PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 36 France PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 37 France PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 38 Italy PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 39 Italy PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 40 Italy PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 41 Italy PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 42 Spain PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 43 Spain PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 44 Spain PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 45 Spain PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific PEGylated Proteins Market, by Country, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 51 China PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 52 China PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 53 China PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 54 China PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 55 Japan PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 56 Japan PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 57 Japan PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 58 Japan PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 59 India PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 60 India PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 61 India PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 62 India PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 63 South Korea PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 64 South Korea PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 65 South Korea PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 66 South Korea PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 67 Australia PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 68 Australia PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 69 Australia PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 70 Australia PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 71 Latin America PEGylated Proteins Market, by Country, 2018 - 2030 (USD Million)
  • Table 72 Latin America PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 73 Latin America PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 74 Latin America PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 75 Latin America PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 76 Brazil PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 77 Brazil PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 78 Brazil PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 79 Brazil PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 80 Mexico PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 81 Mexico PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 82 Mexico PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 83 Mexico PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 84 Argentina PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 85 Argentina PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 86 Argentina PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 87 Argentina PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 88 Middle East & Africa PEGylated Proteins Market, by Country, 2018 - 2030 (USD Million)
  • Table 89 Middle East & Africa PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 90 Middle East & Africa PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 91 Middle East & Africa PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 92 Middle East & Africa PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 93 South Africa PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 94 South Africa PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 95 South Africa PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 96 South Africa PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 97 Saudi Arabia PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 98 Saudi Arabia PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 99 Saudi Arabia PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 100 Saudi Arabia PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 101 UAE PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 102 UAE PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 103 UAE PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 104 UAE PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain - Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 PEGylated Proteins, Market Segmentation
  • Fig. 8 Market Snapshot, 2021
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 15 Global PEGylated Proteins Market, Product & Services Outlook: Key Takeaways
  • Fig. 16 Global PEGylated Proteins Market: Product & Services Movement Analysis
  • Fig. 17 Global PEGylated Proteins Market, for Consumables, 2018 - 2030 (USD Million)
  • Fig. 18 Global PEGylated Proteins Market, for Services, 2018 - 2030 (USD Million)
  • Fig. 19 Global PEGylated Proteins Market, Protein Type Outlook: Key Takeaways
  • Fig. 20 Global PEGylated Proteins Market: Protein Type Movement Analysis
  • Fig. 21 Global PEGylated Proteins Market, for Colony - stimulating factor, 2018 - 2030 (USD Million)
  • Fig. 22 Global PEGylated Proteins Market, for Interferons, 2018 - 2030 (USD Million)
  • Fig. 23 Global PEGylated Proteins Market, for Erythropoietin, 2018 - 2030 (USD Million)
  • Fig. 24 Global PEGylated Proteins Market, for Recombinant factor VII, 2018 - 2030 (USD Million)
  • Fig. 25 Global PEGylated Proteins Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 26 Global PEGylated Proteins Market, Application Outlook: Key Takeaways
  • Fig. 27 Global PEGylated Proteins Market: Application Movement Analysis
  • Fig. 28 Global PEGylated Proteins Market, for Cancer, 2018 - 2030 (USD Million)
  • Fig. 29 Global PEGylated Proteins Market, for Autoimmune diseases, 2018 - 2030 (USD Million)
  • Fig. 30 Global PEGylated Proteins Market, for Hepatitis, 2018 - 2030 (USD Million)
  • Fig. 31 Global PEGylated Proteins Market, for Multiple sclerosis, 2018 - 2030 (USD Million)
  • Fig. 32 Global PEGylated Proteins Market, for Hemophilia, 2018 - 2030 (USD Million)
  • Fig. 33 Global PEGylated Proteins Market, for Gastrointestinal disorders, 2018 - 2030 (USD Million)
  • Fig. 34 Global PEGylated Proteins Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 35 Global PEGylated Proteins Market, End - user Outlook: Key Takeaways
  • Fig. 36 Global PEGylated Proteins Market: End - user Movement Analysis
  • Fig. 37 Global PEGylated Proteins Market, for Pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
  • Fig. 38 Global PEGylated Proteins Market, for Contract research organizations, 2018 - 2030 (USD Million)
  • Fig. 39 Global PEGylated Proteins Market, for Academic & research institutes, 2018 - 2030 (USD Million)
  • Fig. 40 Regional Marketplace: Key Takeaways
  • Fig. 41 Global PEGylated Proteins Market: Regional Movement Analysis
  • Fig. 42 North America PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 44 Canada PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 45 Europe PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 46 Germany PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 47 U.K. PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 48 France PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 49 Italy PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 50 Spain PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 53 China PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 54 India PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 55 Australia PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 59 Mexico PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 62 South Africa PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 63 Saudi Arabia PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 64 UAE PEGylated Proteins Market, 2018 - 2030 (USD Million)